<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">133</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2018-5-1-26-34</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Asynchronous replication in oncological patients</article-title><trans-title-group xml:lang="ru"><trans-title>Асинхронная репликация у онкологических больных</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mikhailova</surname><given-names>G. F.</given-names></name><name xml:lang="ru"><surname>Михайлова</surname><given-names>Г. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>4 Korolyova St., Obninsk 249036</p></bio><bio xml:lang="ru"><p>249036 Обнинск, ул. Королева, 4</p></bio><email>tais1260@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tsepenko</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Цепенко</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>4 Korolyova St., Obninsk 249036</p></bio><bio xml:lang="ru"><p>249036 Обнинск, ул. Королева, 4</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shkavrova</surname><given-names>T. G.</given-names></name><name xml:lang="ru"><surname>Шкаврова</surname><given-names>Т. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>4 Korolyova St., Obninsk 249036</p></bio><bio xml:lang="ru"><p>249036 Обнинск, ул. Королева, 4</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Goloub</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Голуб</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>4 Korolyova St., Obninsk 249036</p></bio><bio xml:lang="ru"><p>249036 Обнинск, ул. Королева, 4</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Center of Radiology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Медицинский радиологический научный центр им А.Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2018</year></pub-date><volume>5</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>26</fpage><lpage>34</lpage><history><date date-type="received" iso-8601-date="2018-05-14"><day>14</day><month>05</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-05-14"><day>14</day><month>05</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Mikhailova G.F., Tsepenko V.V., Shkavrova T.G., Goloub E.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Михайлова Г.Ф., Цепенко В.В., Шкаврова Т.Г., Голуб Е.В.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Mikhailova G.F., Tsepenko V.V., Shkavrova T.G., Goloub E.V.</copyright-holder><copyright-holder xml:lang="ru">Михайлова Г.Ф., Цепенко В.В., Шкаврова Т.Г., Голуб Е.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/133">https://umo.abvpress.ru/jour/article/view/133</self-uri><abstract xml:lang="en"><p>Epigenetics is a science studying mechanisms of heritable changes in gene function that occur without a change in the DNA sequence. One of the most important marks of epigenetic misbalance of cell genome is an replication asynchrony of genes with biallelic expression. Interphase fluorescence in situ hybridization (I-FISH) in phytohaemagglutinin-stimulated lymphocytes of peripheral blood is a proper method of estimation of aberrant DNA replication time e. g. DNA replication asynchrony. In this review we analyzed reports referring to asynchronous DNA replication of biallelically expressed genes in lymphocytes of peripheral blood of cancer patients. Analysis shows the DNA replication asynchrony is a nonspecific tumor marker observing both in tumor cells and lymphocytes of peripheral blood in oncohematological patients and patients with solid tumors. It’s stated the frequency of lymphocytes with asynchronous DNA replication of studied genes in cancer patients is increased significantly compares with healthy donors and is enhanced during malignance process. It gives the opportunity of potential using asynchronous replication as molecular genetic marker for cancer patients early revealing.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>asynchronous replication</kwd><kwd>fluorescence in situ hybridization</kwd><kwd>peripheral blood lymphocyte</kwd><kwd>cancer biomarker</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>асинхронная репликация</kwd><kwd>флуоресцентная in situ гибридизация</kwd><kwd>лимфоциты периферической крови</kwd><kwd>онкологический биомаркер</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Cancer Biomarkers. Minimal and noninvasive early diagnosis and prognosis. Eds. D. Barh, A. Carpi, M. Verma, M.L. Gunduz. N.-Y.: CRC Press, 2014. P. 929. DOI: 10.1201/b16389.</mixed-citation><mixed-citation xml:lang="ru">Cancer Biomarkers. Minimal and noninvasive early diagnosis and prognosis. Eds. D. Barh, A. Carpi, M. Verma, M.L. Gunduz. N.-Y.: CRC Press, 2014. P. 929. DOI: 10.1201/b16389.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Holdenrieder S., Pagliaro L., Morgenstern D., Dayyani F. Clinically meaningful use of blood tumor markers in oncology. Biomed Res Int 2016;2016: 9795269. DOI: 10.1155/2016/9795269. PMID: 28042579.</mixed-citation><mixed-citation xml:lang="ru">Holdenrieder S., Pagliaro L., Morgenstern D., Dayyani F. Clinically meaningful use of blood tumor markers in oncology. Biomed Res Int 2016;2016: 9795269. DOI: 10.1155/2016/9795269. PMID: 28042579.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Duffy M.J., O’Donovan N., McDermott E., Crown J. Validated biomarkers: the key to precision treatment in patients with breast cancer. Breast 2016;29:192–201. DOI: 10.1016/j.breast.2016.07.009. PMID: 27521224.</mixed-citation><mixed-citation xml:lang="ru">Duffy M.J., O’Donovan N., McDermott E., Crown J. Validated biomarkers: the key to precision treatment in patients with breast cancer. Breast 2016;29:192–201. DOI: 10.1016/j.breast.2016.07.009. PMID: 27521224.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Залетаев Д.В., Стрельников В.В., Немцова М.В. и др. Структурно-функциональный анализ опухолевых геномов и разработка тест-систем для ран- ней диагностики, прогноза течения и оптимизации терапии злокачественных новообразований. Вестник РАМН 2013;9:7–14. [Zaletaev D.V., Strelnikov V.V., Nemtsov M.V. et al. Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization. Vestnik RAMN = Annals of the Russian Academy of Medical Sciences 2013;9:7–14. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Залетаев Д.В., Стрельников В.В., Немцова М.В. и др. Структурно-функциональный анализ опухолевых геномов и разработка тест-систем для ран- ней диагностики, прогноза течения и оптимизации терапии злокачественных новообразований. Вестник РАМН 2013;9:7–14. [Zaletaev D.V., Strelnikov V.V., Nemtsov M.V. et al. Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization. Vestnik RAMN = Annals of the Russian Academy of Medical Sciences 2013;9:7–14. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Kamel H.F.M., Al-Amodi H.S.A.B. Exploitation of gene expression and cancer biomarkers in paving the path to era of personalized medicine. Genomics Proteomics Bioinformatics 2017;15(4):220–35. DOI: 10.1016/j.gpb.2016.11.005. PMID: 28813639.</mixed-citation><mixed-citation xml:lang="ru">Kamel H.F.M., Al-Amodi H.S.A.B. Exploitation of gene expression and cancer biomarkers in paving the path to era of personalized medicine. Genomics Proteomics Bioinformatics 2017;15(4):220–35. DOI: 10.1016/j.gpb.2016.11.005. PMID: 28813639.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Cree I.A., Charlton P. Molecular chess? Hallmarks of anti-cancer drug resistance. BMC Cancer 2017;17(1):10. DOI: 10.1186/s12885-016-2999-1. PMID: 28056859.</mixed-citation><mixed-citation xml:lang="ru">Cree I.A., Charlton P. Molecular chess? Hallmarks of anti-cancer drug resistance. BMC Cancer 2017;17(1):10. DOI: 10.1186/s12885-016-2999-1. PMID: 28056859.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Эпигенетика. Под ред. С.Д. Эллиса, Т. Дженювейна, Д. Рейнберга, М.Л. Капаррос. М.: Техносфера, 2010. С. 495. [Epigenetics. Eds. C.D. Allis, T. Jenuwein, D. Reinberg, M.L. Caparros. Moscow: Tekhnosphera, 2010. P. 495. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Эпигенетика. Под ред. С.Д. Эллиса, Т. Дженювейна, Д. Рейнберга, М.Л. Капаррос. М.: Техносфера, 2010. С. 495. [Epigenetics. Eds. C.D. Allis, T. Jenuwein, D. Reinberg, M.L. Caparros. Moscow: Tekhnosphera, 2010. P. 495. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Колесникова Т.Д. Механизмы про- странственно-временной регуляции репликации. Молекулярная биология 2013;47(1):12–37. [Kolesnikova T.D. Regulation of DNA replication timing. Molekulyarnaya biologiya = Molecular Biology 2013;47(1):12–37. (In Russ.)]. DOI: 10.7868/S0026898412060110.</mixed-citation><mixed-citation xml:lang="ru">Колесникова Т.Д. Механизмы про- странственно-временной регуляции репликации. Молекулярная биология 2013;47(1):12–37. [Kolesnikova T.D. Regulation of DNA replication timing. Molekulyarnaya biologiya = Molecular Biology 2013;47(1):12–37. (In Russ.)]. DOI: 10.7868/S0026898412060110.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Dimitrova D.S., Gilbert D.M. The spatial position and replication timing of chromosomal domains are both established in early G1 phase. Mol Cell 1999;4(6):983–93. DOI: 10.1016/S1097-2765(00)80227-0. PMID: 10635323.</mixed-citation><mixed-citation xml:lang="ru">Dimitrova D.S., Gilbert D.M. The spatial position and replication timing of chromosomal domains are both established in early G1 phase. Mol Cell 1999;4(6):983–93. DOI: 10.1016/S1097-2765(00)80227-0. PMID: 10635323.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Sadoni N., Cardoso M.C., Stelzer E.H. et al. Stable chromosomal units determine the spatial and temporal organization of DNA replication. J Cell Sci 2004;117 (Pt 22):5353–65. DOI: 10.1242/jcs.01412. PMID: 15466893.</mixed-citation><mixed-citation xml:lang="ru">Sadoni N., Cardoso M.C., Stelzer E.H. et al. Stable chromosomal units determine the spatial and temporal organization of DNA replication. J Cell Sci 2004;117 (Pt 22):5353–65. DOI: 10.1242/jcs.01412. PMID: 15466893.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Hiratani I., Gilbert D.M. Replication timing as an epigenetic mark. Epigenetics 2009;4(2):93–7. DOI: 10.4161/ epi.4.2.7772. PMID: 19242104.</mixed-citation><mixed-citation xml:lang="ru">Hiratani I., Gilbert D.M. Replication timing as an epigenetic mark. Epigenetics 2009;4(2):93–7. DOI: 10.4161/ epi.4.2.7772. PMID: 19242104.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Pope B.D., Gilbert D.M. The replication domain model: regulating replicon firing in the context of large-scale chromosome architecture. J Mol Biol 2013;425(23): 4690–5. DOI: 10.1016/j.jmb.2013.04.014. PMID: 23603017.</mixed-citation><mixed-citation xml:lang="ru">Pope B.D., Gilbert D.M. The replication domain model: regulating replicon firing in the context of large-scale chromosome architecture. J Mol Biol 2013;425(23): 4690–5. DOI: 10.1016/j.jmb.2013.04.014. PMID: 23603017.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Gilbert D.M. Cell fate transitions and the replication timing decision point. J Cell Biol 2010;191(5):899–903. DOI: 10.1083/jcb.201007125. PMID: 21115801.</mixed-citation><mixed-citation xml:lang="ru">Gilbert D.M. Cell fate transitions and the replication timing decision point. J Cell Biol 2010;191(5):899–903. DOI: 10.1083/jcb.201007125. PMID: 21115801.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Reddy K.L., Feinberg A.P. Higher order chromatin organization in cancer. Semin Cancer Biol 2013;23(2):109–15. DOI: 10.1016/j.semcancer.2012.12.001. PMID: 23266653.</mixed-citation><mixed-citation xml:lang="ru">Reddy K.L., Feinberg A.P. Higher order chromatin organization in cancer. Semin Cancer Biol 2013;23(2):109–15. DOI: 10.1016/j.semcancer.2012.12.001. PMID: 23266653.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Loupart M., Krause S., Heck M.S. Aberrant replication timing induces defective chromosome condensation in Drosophila ORC2 mutants. Curr Biol 2000;10(24):1547–56. DOI: 10.1016/S0960-9822(00)00844-7. PMID: 11137005.</mixed-citation><mixed-citation xml:lang="ru">Loupart M., Krause S., Heck M.S. Aberrant replication timing induces defective chromosome condensation in Drosophila ORC2 mutants. Curr Biol 2000;10(24):1547–56. DOI: 10.1016/S0960-9822(00)00844-7. PMID: 11137005.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Pflumm M.F., Botchan M.R. Orc mutants arrest in metaphase with abnormally condensed chromosomes. Development 2001;128(9):1697–707. PMID: 11290306.</mixed-citation><mixed-citation xml:lang="ru">Pflumm M.F., Botchan M.R. Orc mutants arrest in metaphase with abnormally condensed chromosomes. Development 2001;128(9):1697–707. PMID: 11290306.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Breger K.S., Smith L., Thayer M.J. Engineering translocations with delayed replication: evidence for cis control of chromosome replication timing. Hum Mol Genet 2005;14(19):2813–27. DOI: 10.1093/hmg/ddi314. PMID: 16115817.</mixed-citation><mixed-citation xml:lang="ru">Breger K.S., Smith L., Thayer M.J. Engineering translocations with delayed replication: evidence for cis control of chromosome replication timing. Hum Mol Genet 2005;14(19):2813–27. DOI: 10.1093/hmg/ddi314. PMID: 16115817.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Chang B.H., Smith L., Huang J., Thayer M.J. Chromosomes with delayed replication timing lead to checkpoint activation, delayed recruitment of Aurora B and chromosome instability. Oncogene 2007;26(13):1852–61. DOI: 10.1038/sj.onc.1209995. PMID: 17001311.</mixed-citation><mixed-citation xml:lang="ru">Chang B.H., Smith L., Huang J., Thayer M.J. Chromosomes with delayed replication timing lead to checkpoint activation, delayed recruitment of Aurora B and chromosome instability. Oncogene 2007;26(13):1852–61. DOI: 10.1038/sj.onc.1209995. PMID: 17001311.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Lang G.I., Murray A.W. Mutation rates across budding yeast chromosome VI are correlated with replication timing. Genome Biol Evol 2011;3:799–811. DOI: 10.1093/gbe/evr054. PMID: 21666225.</mixed-citation><mixed-citation xml:lang="ru">Lang G.I., Murray A.W. Mutation rates across budding yeast chromosome VI are correlated with replication timing. Genome Biol Evol 2011;3:799–811. DOI: 10.1093/gbe/evr054. PMID: 21666225.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Donley N., Stoffregen E.P., Smith L. et al. Asynchronous replication, mono-allelic expression, and long range Cis-effects of ASAR6. PLoS Genet 2013;9(4):e1003423. DOI: 10.1371/ journal.pgen.1003423. PMID: 23593023.</mixed-citation><mixed-citation xml:lang="ru">Donley N., Stoffregen E.P., Smith L. et al. Asynchronous replication, mono-allelic expression, and long range Cis-effects of ASAR6. PLoS Genet 2013;9(4):e1003423. DOI: 10.1371/ journal.pgen.1003423. PMID: 23593023.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. De S., Michor F. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol 2011;29(11):1103–8. DOI: 10.1038/nbt.2030. PMID: 22101487.</mixed-citation><mixed-citation xml:lang="ru">De S., Michor F. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol 2011;29(11):1103–8. DOI: 10.1038/nbt.2030. PMID: 22101487.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Woo Y.H., Li W.H. DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat Commun 2012;3:1004. DOI: 10.1038/ ncomms1982. PMID: 22893128.</mixed-citation><mixed-citation xml:lang="ru">Woo Y.H., Li W.H. DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat Commun 2012;3:1004. DOI: 10.1038/ ncomms1982. PMID: 22893128.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Soutoglou E., Misteli T. On the contribution of spatial genome organization to cancerous chromosome translocations. J Natl Cancer Inst Monogr 2008;(39):16–9. DOI: 10.1093/jncimonographs/lgn017. PMID: 18647996.</mixed-citation><mixed-citation xml:lang="ru">Soutoglou E., Misteli T. On the contribution of spatial genome organization to cancerous chromosome translocations. J Natl Cancer Inst Monogr 2008;(39):16–9. DOI: 10.1093/jncimonographs/lgn017. PMID: 18647996.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Engreitz J.M., Agarwala V., Mirny L.A. Three-dimensional genome architecture influences partner selection for chromosomal translocations in human disease. PLoS One 2012;7(9):e44196. DOI: 10.1371/journal.pone.0044196. PMID: 23028501.</mixed-citation><mixed-citation xml:lang="ru">Engreitz J.M., Agarwala V., Mirny L.A. Three-dimensional genome architecture influences partner selection for chromosomal translocations in human disease. PLoS One 2012;7(9):e44196. DOI: 10.1371/journal.pone.0044196. PMID: 23028501.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Meaburn K.J., Misteli T., Soutoglou E. Spatial genome organization in the formation of chromosomal translocations. Semin Cancer Biol 2007;17(1):80–90. DOI: 10.1016/j.semcancer.2006.10.008. PMID: 17137790.</mixed-citation><mixed-citation xml:lang="ru">Meaburn K.J., Misteli T., Soutoglou E. Spatial genome organization in the formation of chromosomal translocations. Semin Cancer Biol 2007;17(1):80–90. DOI: 10.1016/j.semcancer.2006.10.008. PMID: 17137790.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Ozeri-Galai E., Bester A.C., Kerem B. The complex basis underlying common fragile site instability in cancer. Trends Genet 2012;28(6):295–302. DOI: 10.1016/j.tig.2012.02.006. PMID: 22465609.</mixed-citation><mixed-citation xml:lang="ru">Ozeri-Galai E., Bester A.C., Kerem B. The complex basis underlying common fragile site instability in cancer. Trends Genet 2012;28(6):295–302. DOI: 10.1016/j.tig.2012.02.006. PMID: 22465609.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Simon I., Tenzen T., Reubinoff B.E. et al. Asynchronous replication of imprinted genes is established in the gametes and maintained during development. Nature 1999;401(6756):929–32. DOI: 10.1038/44866. PMID: 10553911.</mixed-citation><mixed-citation xml:lang="ru">Simon I., Tenzen T., Reubinoff B.E. et al. Asynchronous replication of imprinted genes is established in the gametes and maintained during development. Nature 1999;401(6756):929–32. DOI: 10.1038/44866. PMID: 10553911.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Gunaratne P.H., Nakao M., Ledbetter D.H. et al. Tissue-specific and allele-specific replication timing control in the imprinted human Prader-Willi syndrome region. Genes Dev 1995;9(7):808–20. DOI: 10.1101/ gad.9.7.808. PMID: 7705658.</mixed-citation><mixed-citation xml:lang="ru">Gunaratne P.H., Nakao M., Ledbetter D.H. et al. Tissue-specific and allele-specific replication timing control in the imprinted human Prader-Willi syndrome region. Genes Dev 1995;9(7):808–20. DOI: 10.1101/ gad.9.7.808. PMID: 7705658.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. LaSalle J.M., Lalande M. Domain organization of allele-specific replication within the GABRB3 gene cluster requires a biparental 15q11–13 contribution. Nat Genet 1995;9(4):386–94. DOI: 10.1038/ng0495-386. PMID: 7795644.</mixed-citation><mixed-citation xml:lang="ru">LaSalle J.M., Lalande M. Domain organization of allele-specific replication within the GABRB3 gene cluster requires a biparental 15q11–13 contribution. Nat Genet 1995;9(4):386–94. DOI: 10.1038/ng0495-386. PMID: 7795644.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Torchia B.S., Call L.M., Migeon B.R. DNA replication analysis of FMR1, XIST, and factor 8C loci by FISH shows nontranscribed X-linked genes replicate late. Am J Hum Genet 1994;55(1):96–104. PMID: 8023856.</mixed-citation><mixed-citation xml:lang="ru">Torchia B.S., Call L.M., Migeon B.R. DNA replication analysis of FMR1, XIST, and factor 8C loci by FISH shows nontranscribed X-linked genes replicate late. Am J Hum Genet 1994;55(1):96–104. PMID: 8023856.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Yeshaya J., Shalgi R., Shohat M., Avivi L. FISH-detected delay in replication timing of mutated FMR1 alleles on both active and inactive X-chromosomes. Hum Genet 1999;105(1–2):86–97. DOI: 10.1007/s004399900081. PMID: 10480360.</mixed-citation><mixed-citation xml:lang="ru">Yeshaya J., Shalgi R., Shohat M., Avivi L. FISH-detected delay in replication timing of mutated FMR1 alleles on both active and inactive X-chromosomes. Hum Genet 1999;105(1–2):86–97. DOI: 10.1007/s004399900081. PMID: 10480360.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Koren A., McCarroll S.A. Random replication of the inactive X chromosome. Genome Res 2014;24(1):64–9. DOI: 10.1101/gr.161828.113. PMID: 24065775.</mixed-citation><mixed-citation xml:lang="ru">Koren A., McCarroll S.A. Random replication of the inactive X chromosome. Genome Res 2014;24(1):64–9. DOI: 10.1101/gr.161828.113. PMID: 24065775.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Goldmit M., Bergman Y. Monoallelic gene expression: a repertoire of recurrent themes. Immun Rev 2004;200(1):197–214. DOI: 10.1111/j.0105-2896.2004.00158.x. PMID: 15242406.</mixed-citation><mixed-citation xml:lang="ru">Goldmit M., Bergman Y. Monoallelic gene expression: a repertoire of recurrent themes. Immun Rev 2004;200(1):197–214. DOI: 10.1111/j.0105-2896.2004.00158.x. PMID: 15242406.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Chess A., Simon I., Cedar H., Axel R. Allelic inactivation regulates olfactory receptor gene expression. Cell 1994;78(5):823–34. DOI: 10.1016/S0092-8674(94)90562-2. PMID: 8087849.</mixed-citation><mixed-citation xml:lang="ru">Chess A., Simon I., Cedar H., Axel R. Allelic inactivation regulates olfactory receptor gene expression. Cell 1994;78(5):823–34. DOI: 10.1016/S0092-8674(94)90562-2. PMID: 8087849.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Mostoslavsky R., Singh N., Tenzen T. et al. Asynchronous replication and allelic exclusion in the immune system. Nature 2001;414(6860):221–5. DOI: 10.1038/35102606. PMID: 11700561.</mixed-citation><mixed-citation xml:lang="ru">Mostoslavsky R., Singh N., Tenzen T. et al. Asynchronous replication and allelic exclusion in the immune system. Nature 2001;414(6860):221–5. DOI: 10.1038/35102606. PMID: 11700561.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Ensminger A.W., Chess A. Coordinated replication timing of monoallelically expressed genes along human autosomes. Hum Mol Genet 2004;13(6):651–8. DOI: 10.1093/hmg/ddh062. PMID: 14734625.</mixed-citation><mixed-citation xml:lang="ru">Ensminger A.W., Chess A. Coordinated replication timing of monoallelically expressed genes along human autosomes. Hum Mol Genet 2004;13(6):651–8. DOI: 10.1093/hmg/ddh062. PMID: 14734625.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Gribnau J., Hochedlinger K., Hata K. et al. Asynchronous replication timing of imprinted loci is independent of DNA methylation, but consistent with differential subnuclear localization. Genes Dev 2003;17(6):759–3. DOI: 10.1101/gad.1059603. PMID: 12651894.</mixed-citation><mixed-citation xml:lang="ru">Gribnau J., Hochedlinger K., Hata K. et al. Asynchronous replication timing of imprinted loci is independent of DNA methylation, but consistent with differential subnuclear localization. Genes Dev 2003;17(6):759–3. DOI: 10.1101/gad.1059603. PMID: 12651894.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38. Bergman Y., Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat Rev Immun 2004;4(10):754–61. DOI: 10.1038/nri1458. PMID: 15459667.</mixed-citation><mixed-citation xml:lang="ru">Bergman Y., Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat Rev Immun 2004;4(10):754–61. DOI: 10.1038/nri1458. PMID: 15459667.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39. Donley N., Thayer M.J. DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is associated with increased genomic instability. Semin Cancer Biol 2013;23(2):80–9. DOI: 10.1016/ j.semcancer.2013.01.001. PMID: 23327985.</mixed-citation><mixed-citation xml:lang="ru">Donley N., Thayer M.J. DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is associated with increased genomic instability. Semin Cancer Biol 2013;23(2):80–9. DOI: 10.1016/ j.semcancer.2013.01.001. PMID: 23327985.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40. Liu L., De S., Michor F. DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes. Nat Commun 2013;4:1502. DOI: 10.1038/ncomms2502. PMID: 23422670.</mixed-citation><mixed-citation xml:lang="ru">Liu L., De S., Michor F. DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes. Nat Commun 2013;4:1502. DOI: 10.1038/ncomms2502. PMID: 23422670.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">41. Tomasetti C., Li L., Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 2017;355(6331):1330–4. DOI: 10.1126/science.aaf9011. PMID: 28336671.</mixed-citation><mixed-citation xml:lang="ru">Tomasetti C., Li L., Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 2017;355(6331):1330–4. DOI: 10.1126/science.aaf9011. PMID: 28336671.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">42. Ryba T., Battaglia D., Chang B.H. et al. Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia. Genome Res 2012;22(10):1833–44. DOI: 10.1101/gr.138511.112. PMID: 22628462.</mixed-citation><mixed-citation xml:lang="ru">Ryba T., Battaglia D., Chang B.H. et al. Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia. Genome Res 2012;22(10):1833–44. DOI: 10.1101/gr.138511.112. PMID: 22628462.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">43. Selig S., Okumura K., Ward D.C., Cedar H. Delineation of DNA replication time zones by fluorescence in situ hybridization. EMBO J 1992;11(3):1217–25. DOI: 10.1016/0962-8924(92)90032-I. PMID: 1547781.</mixed-citation><mixed-citation xml:lang="ru">Selig S., Okumura K., Ward D.C., Cedar H. Delineation of DNA replication time zones by fluorescence in situ hybridization. EMBO J 1992;11(3):1217–25. DOI: 10.1016/0962-8924(92)90032-I. PMID: 1547781.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">44. Amiel A., Litmanovich T., Gaber E. et al. Asynchronous replication of p53 and 21q22 loci in chronic lymphocytic leukemia. Hum Genet 1997;101(2):219–22. DOI: 10.1007/s004390050619. PMID: 9402974.</mixed-citation><mixed-citation xml:lang="ru">Amiel A., Litmanovich T., Gaber E. et al. Asynchronous replication of p53 and 21q22 loci in chronic lymphocytic leukemia. Hum Genet 1997;101(2):219–22. DOI: 10.1007/s004390050619. PMID: 9402974.</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">45. Amiel A., Litmanovitch T., Lishner M. et al. Temporal differences in replication timing of homologous loci in malignant cells derived from CML and lymphoma patients. Genes Chromosomes Cancer 1998;22(3):225–31. DOI: 10.1002/ (SICI)1098-2264(199807)22:33.0.CO;2-Y. PMID: 9624534.</mixed-citation><mixed-citation xml:lang="ru">Amiel A., Litmanovitch T., Lishner M. et al. Temporal differences in replication timing of homologous loci in malignant cells derived from CML and lymphoma patients. Genes Chromosomes Cancer 1998;22(3):225–31. DOI: 10.1002/ (SICI)1098-2264(199807)22:33.0.CO;2-Y. PMID: 9624534.</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">46. Dotan Z.A., Dotan A., Litmanovitch T. et al. Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: a novel genetic alteration associated with malignancy. Genes Chromosomes Cancer 2000;27(3):270–7. DOI: 10.1002/(SICI)1098-2264(200003) 27:33.0.CO;2-7. PMID: 10679916.</mixed-citation><mixed-citation xml:lang="ru">Dotan Z.A., Dotan A., Litmanovitch T. et al. Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: a novel genetic alteration associated with malignancy. Genes Chromosomes Cancer 2000;27(3):270–7. DOI: 10.1002/(SICI)1098-2264(200003) 27:33.0.CO;2-7. PMID: 10679916.</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">47. Reish O., Orlovski A., Mashevich M. et al. Modified allelic replication in lymphocytes of patients with neurofibromatosis type 1. Cancer Genet Cytogenet 2003;143(2):133–9. DOI: 10.1016/S0165-4608(02)00858-0. PMID: 12781447.</mixed-citation><mixed-citation xml:lang="ru">Reish O., Orlovski A., Mashevich M. et al. Modified allelic replication in lymphocytes of patients with neurofibromatosis type 1. Cancer Genet Cytogenet 2003;143(2):133–9. DOI: 10.1016/S0165-4608(02)00858-0. PMID: 12781447.</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">48. Nagler A., Cytron S., Mashevich M. et al. The aberrant asynchronous replication – characterizing lymphocytes of cancer patients – is erased following stem cell transplantation. BMC Cancer 2010;10(1):230. DOI: 10.1186/ 1471-2407-10-230. PMID: 20497575.</mixed-citation><mixed-citation xml:lang="ru">Nagler A., Cytron S., Mashevich M. et al. The aberrant asynchronous replication – characterizing lymphocytes of cancer patients – is erased following stem cell transplantation. BMC Cancer 2010;10(1):230. DOI: 10.1186/ 1471-2407-10-230. PMID: 20497575.</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">49. Dotan Z.A., Dotan A., Ramon J., Avivi L. Altered mode of allelic replication accompanied by aneuploidy in peripheral blood lymphocytes of prostate cancer patients. Int J Cancer 2004;111(1):60–6. DOI: 10.1002/ijc.20237. PMID: 15185343.</mixed-citation><mixed-citation xml:lang="ru">Dotan Z.A., Dotan A., Ramon J., Avivi L. Altered mode of allelic replication accompanied by aneuploidy in peripheral blood lymphocytes of prostate cancer patients. Int J Cancer 2004;111(1):60–6. DOI: 10.1002/ijc.20237. PMID: 15185343.</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">50. Grinberg-Rashi H., Cytron S., GelmanKohan Z. et al. Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients. Neoplasia 2010;12(8):668–74. DOI: 10.1593/neo.10568. PMID: 20689761.</mixed-citation><mixed-citation xml:lang="ru">Grinberg-Rashi H., Cytron S., GelmanKohan Z. et al. Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients. Neoplasia 2010;12(8):668–74. DOI: 10.1593/neo.10568. PMID: 20689761.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">51. Litmanovitch T., Altaras M.M., Dotan A., Avivi L. Asynchronous replication of homologous alpha-satellite DNA loci in man is associated with nondisjunction. Cytogenet Cell Genet 1998;81(1):26–35. DOI: 10.1159/000015003. PMID: 9691171.</mixed-citation><mixed-citation xml:lang="ru">Litmanovitch T., Altaras M.M., Dotan A., Avivi L. Asynchronous replication of homologous alpha-satellite DNA loci in man is associated with nondisjunction. Cytogenet Cell Genet 1998;81(1):26–35. DOI: 10.1159/000015003. PMID: 9691171.</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">52. Korenstein-Ilan A., Amiel A., Lalezari S. et al. Allele-specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies. Cancer Genet Cytogenet 2002;139(2):97–103. DOI: 10.1016/S0165-4608(02)00610-6. PMID: 12550768.</mixed-citation><mixed-citation xml:lang="ru">Korenstein-Ilan A., Amiel A., Lalezari S. et al. Allele-specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies. Cancer Genet Cytogenet 2002;139(2):97–103. DOI: 10.1016/S0165-4608(02)00610-6. PMID: 12550768.</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">53. Dotan Z.A., Dotan A., Ramon J., Avivi L. Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients. BMC Cancer 2008;8(1):390. DOI: 10.1186/1471-2407-8-390. PMID: 19109880.</mixed-citation><mixed-citation xml:lang="ru">Dotan Z.A., Dotan A., Ramon J., Avivi L. Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients. BMC Cancer 2008;8(1):390. DOI: 10.1186/1471-2407-8-390. PMID: 19109880.</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">54. Hanna M.O., Zayed N.A., Darwish H., Girgis S.I. Asynchronous DNA replication and aneuploidy in lymphocytes of hepatocellular carcinoma patients. Cancer Genet 2012;205(12):636–43. DOI: 10.1016/j.cancergen.2012.10.006. PMID: 23182962.</mixed-citation><mixed-citation xml:lang="ru">Hanna M.O., Zayed N.A., Darwish H., Girgis S.I. Asynchronous DNA replication and aneuploidy in lymphocytes of hepatocellular carcinoma patients. Cancer Genet 2012;205(12):636–43. DOI: 10.1016/j.cancergen.2012.10.006. PMID: 23182962.</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">55. Amiel A., Kirgner I., Gaber E. et al. Replication pattern in cancer: asynchronous replication in multiple myeloma and in monoclonal gammopathy. Cancer Genet Cytogenet 1999;108(1):32–7. DOI: 10.1016/S0165-4608(98)00107-1. PMID: 9973921.</mixed-citation><mixed-citation xml:lang="ru">Amiel A., Kirgner I., Gaber E. et al. Replication pattern in cancer: asynchronous replication in multiple myeloma and in monoclonal gammopathy. Cancer Genet Cytogenet 1999;108(1):32–7. DOI: 10.1016/S0165-4608(98)00107-1. PMID: 9973921.</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">56. Amiel A., Kitay-Cohen Y., Fejgin M.D., Lishner M. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 2000;28(2):156–60. DOI: 10.1016/S0301-472X(99)00140-X. PMID: 10706071.</mixed-citation><mixed-citation xml:lang="ru">Amiel A., Kitay-Cohen Y., Fejgin M.D., Lishner M. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 2000;28(2):156–60. DOI: 10.1016/S0301-472X(99)00140-X. PMID: 10706071.</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">57. Cytron S., Stepnov E., Bounkin I. et al. Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels. Clin Epigenetics 2011;2(2):383–8. DOI: 10.1007/ s13148-011-0029-3. PMID: 21949550.</mixed-citation><mixed-citation xml:lang="ru">Cytron S., Stepnov E., Bounkin I. et al. Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels. Clin Epigenetics 2011;2(2):383–8. DOI: 10.1007/ s13148-011-0029-3. PMID: 21949550.</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">58. Amiel A., Elis A., Maimon O. et al. Replication status in leukocytes of treated and untreated patients with polycythemia vera and essential thrombocytosis. Cancer Genet Cytogenet 2002;133(1):34–8. DOI: 10.1016/S0165-4608(01)00560-X. PMID: 11890987.</mixed-citation><mixed-citation xml:lang="ru">Amiel A., Elis A., Maimon O. et al. Replication status in leukocytes of treated and untreated patients with polycythemia vera and essential thrombocytosis. Cancer Genet Cytogenet 2002;133(1):34–8. DOI: 10.1016/S0165-4608(01)00560-X. PMID: 11890987.</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">59. Fritz A., Sinha S., Marella N., Berezney R. Alterations in replication timing of cancer-related genes in malignant human breast cancer cells. J Cell Biochem 2013;114(5):1074–83. DOI: 10.1002/jcb.24447. PMID: 23161755.</mixed-citation><mixed-citation xml:lang="ru">Fritz A., Sinha S., Marella N., Berezney R. Alterations in replication timing of cancer-related genes in malignant human breast cancer cells. J Cell Biochem 2013;114(5):1074–83. DOI: 10.1002/jcb.24447. PMID: 23161755.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
